Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed and Refractory Multiple Myeloma (RRMM)

Clinical trial condition

Relapsed and Refractory Multiple Myeloma (RRMM)

Explore clinical trials studying Relapsed and Refractory Multiple Myeloma (RRMM). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed and Refractory Multiple Myeloma (RRMM) trial results

Not Yet Recruiting

SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

NCT07234721

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Completed

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

NCT05673967

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Regeneron Research Facility Tarrytown, New York, United States

View Trial Details

Active, Not Recruiting

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

NCT06479954

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Pfizer Tokyo, Japan

View Trial Details